— Know what they know.
Not Investment Advice

OMER NASDAQ

Omeros Corporation
1W: +5.7% 1M: -10.0% 3M: +49.9% YTD: +6.8% 1Y: +131.7% 3Y: +1322.0% 5Y: +181.2%
$17.49
+1.20 (+7.37%)
After Hours: $17.31 (-0.18, -1.00%)
Weekly Expected Move ±8.4%
$14 $15 $17 $18 $19
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 35 · $1.3B mcap · 69M float · 2.51% daily turnover · Short 64% of daily vol
Credit Risk of going bust: higher than 76% of companies Debt: 6.6% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the third-riskiest tenth, about 1 in 140 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.27 (down 98%), Omeros Corporation would be worth roughly what it owes.
Total debt $83.8M against a stock market value of $1.18B.
Distance to default 2.95 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $52.3M (short-term plus half of long-term), stock volatility 97.6%; Altman Z'' -4.51. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$277M -26.8% ▼
5Y CAGR: +15.1%
Total Liabilities
$460M +14.0% ▲
5Y CAGR: +13.3%
Shareholders Equity
-$183M -630.9% ▼
Cash & Investments
$90M -47.6% ▼
5Y CAGR: +8.2%
Total Debt
$207M -42.7% ▼
5Y CAGR: +1.3%
Net Debt
$204M -42.6% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$11M$101M$11M$7M$3M
Short-Term Investments$124M$56M$184M$165M$87M
Cash & ST Investments$135M$157M$195M$172M$90M
Net Receivables$4M$82M$242M$7M$37M
Inventory$1M$0$0$0$0
Other Current Assets$681K$67K$6M$31M$7M
Total Current Assets$151M$248M$443M$218M$134M
Property, Plant & Equip.$28M$30M$23M$21M$18M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$2M$141M$124M$140M$125M
Total Non-Current Assets$30M$171M$148M$160M$143M
Total Assets$181M$419M$591M$378M$277M
— Liabilities —
Accounts Payable$4M$13M$6M$8M$6M
Short-Term Debt$0$0$94M$9M$21M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$4M$4M$8M$0$30M
Total Current Liabilities$37M$52M$136M$53M$80M
Long-Term Debt$236M$313M$221M$330M$167M
Other Non-Current Liab.$0$1M$126M$2M$200M
Total Non-Current Liabilities$265M$344M$369M$350M$380M
Total Liabilities$302M$395M$505M$403M$460M
— Equity —
Common Stock$616K$626K$628K$611K$580K
Retained Earnings-$873M-$683M-$636M-$754M-$910M
Accumulated OCI$0$0$0-$0$0
Total Stockholders Equity-$121M$24M$86M-$25M-$183M
Total Liabilities & Equity$181M$419M$591M$378M$277M
— Key Metrics —
Total Debt$269M$348M$342M$362M$207M
Net Debt$258M$247M$331M$354M$204M
Total Investments$124M$56M$184M$165M$87M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms